🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT06666868
Starting soon Not applicable

CARD for Community Pharmacy Vaccinations - Phase 2

NCT06666868 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2024-11-05
Last updated
2024-10-31

Condition(s) studied

VaccinationVaccination PainVaccination ReactionVaccination Pharmacy

Investigational drug(s) / intervention(s)

Sustained CARDFirst-time CARD

Sustained CARD: This group is using CARD for the 2nd year in a row in participating pharmacies as the vaccination delivery framework (It was used in the 2023-2024 fall/winter vaccination season and is now being sustained in the 2024-2025 fall/winter vaccination season).

First-time CARD: CARD is being used for the 1st time in participating pharmacies as the vaccination delivery framework (2024-2025 fall/winter vaccination season).

Study summary

This study is phase 2 of a cluster trial integrating the CARD (Comfort Ask Relax System) in community pharmacies affiliated with Wholehealth Pharmacy Partners. It involves continuing CARD in pharmacies randomized to CARD in phase 1 of the trial (2023-2024 fall/winter vaccination season), and initiating CARD in pharmacies randomized to Control (usual care) in phase 1 of the trial. Both groups will use CARD for delivery of vaccinations during the 2024-2025 fall/winter vaccination season.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion Criteria: * clients undergoing vaccination in participating pharmacies and providers working in participating pharmacies Exclusion Criteria: * able to speak and write in English

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Leslie Dan Faculty of Pharmacy, University of Toronto Toronto Ontario

More University of Toronto trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06666868 on ClinicalTrials.gov ↗ ← All trials in Canada